The role of tissue factor in normal pregnancy and in the development of preeclampsia: A review

Biomedical Papers

Volumn 159, Issue 2, 2015, Pages 192-196

  Prochazkova, Jana ^a   Slavik, Ludek ^a   Ulehlova, Jana ^a   Prochazka, Martin ^a,b  

^a UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

^b PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

Inflammation; Preeclampsia; Pregnancy; Thrombosis; Tissue factor

Indexed keywords

THROMBOPLASTIN;

BLOOD; BLOOD CLOTTING; FEMALE; HUMAN; META ANALYSIS; PHYSIOLOGY; PRE-ECLAMPSIA; PREGNANCY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

BLOOD COAGULATION; FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; THROMBOPLASTIN;

EID: 84934280712     PISSN: 12138118     EISSN: 18047521     Source Type: Journal    
DOI: 10.5507/bp.2014.061     Document Type: Editorial

References (76)

1. Chu AJ. Tissue Factor, Blood Coagulation, and Beyond: An Overview. International Journal of Inflammation 2011;Article ID 367284, 30 pages, doi:10.4061/2011/367284
2. Petersen LC, Valentin S, Hedner U. Regulation of the extrinsic pathway system in health and disease: the role of factor VII a and tissue factor pathway inhibitor. Thrombosis Research 1995;79(1):1-47
3. Chu AJ. Tissue factor mediates inflammation. Archives of Biochemistry and Biophysics 2005;440(2):123-32
4. Kittur FS, Manithody C, Morrisey JH, Rezaie AR. The cofactor function of the N-terminal domain of tissue factor. Journal of Biological Chemistry 2004;279(38):39745-9
5. Osterud B, Bjorklid E. Sources of tissue factor. Seminars in Thrombosis and Hemostasis 2006;32(1):11-23
6. Drake TA, Morrisey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Am J Pathol 1989;134:1087-97
7. Flossel C, Luther T, Muller M, Albrecht S, Kasper M. Immuno histochemical detection of tissue factor (TF) in paraffin sections of routinely fixed human tissue. Histochemistry 1994;101:448-53
8. Key NS, Mackman N. Tissue factor and its measurement in whole blood, plasma and microparticles. Seminars in Thrombosis and Hemostasis 2010;36(8):865-75
9. Muller I, Klocke A, Alex M, Kotzch M, Luther T, Morgenstern E, Zieseniss S, Zahler S, Preissner K, Engelmann B. Intravascular tissue factor iniciates coagulation via circulating microvesicles and plateles. FASEB Journal 2003;17:476-8
10. Berckmans RJ, Neiuwland R, Boing AN, Romijn FP, Hack CE, Sturk A. Cell derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 2001;85:639-46
11. Albrecht S, Kotzch M, Siegert G, Luther T, Grossmann H, Grosser M, Muller M. Detection of circulating tissue factor aand factor VII in a normal population. Thromb Haemost 1996;75:772-7
12. Carlsson K, Freskgard, PO, Persson E, Carlsson U, Svensson M. Probing the interface between factor Xa and tissue factor in the quaternary complex tissue factor-factor VIIa-factor Xa-tissue factor pathway inhibitor. Eur J Biochem 2003;270(12):2576-82
13. Mackman N. Role of Tissue Factor in Haemostasis, Thrombosis, and Vascular Development. Arterioscler Thromb Vasc Biol 2004; 24:1015-22
14. Belting M, Ahamed J, Ruf W. Signaling of the tissue factor coagulation pathway in angiogenesis and cancer. Arteiroscler Thromb Vasc Biol 2005;25:1545-50
15. Rosen ED, Chan JCY, Idusogie E, Clotman F, Vlasuk G, Luther T, Jalbert LR, Albrecht S, Zhong L, Lissens A, Schoonjans L, Moons L, Collen D, Castellino FJ, Carmeliet P. Mice lacking factor VII develop normally but suffer fatal perinatal bleeding. Nature 1997;390:290-4
16. Sandset PM. Tissue factor pathway inhibitor (TFPI) – an update. Haemostasis 1996;26:154-65
17. Broze Jr GJ. Tissue factor pathway inhibitor. Thromb Haemost 1995;74:90-3
18. Osterud B, Bajaj MS, Bajaj SP. Sites of tissue factor pathway inhibitor (TFPI) and tissue factor expression under physiological and pathological conditions. Thromb Haemost 1995;73:873-5
19. Van Hinsbergh VWM: Endothelium – role in regulation of coagulation and inflammation. Semin Imunopathol 2012;34(1):93-106
20. Marmur JD, Thiruvikraman SV, Fyfe BS, Guha A, Sharma SK, Ambrose JA, Fallon JT, Nemerson Y, Taubman MB. Identification of active tissue factor in human coronary atheroma. Circulation 1996;94:1226-32
21. Taubman MB, Fallon JT, Schecter AD, Giesen P, Mendlowitz M, Fyfe BS, Marmur JD, Nemerson Y. Tissue factor in the pathogenesis of atherosclerosis. Thromb Haemost 1997;78:200-4
22. Bouma BN, Meijers JC. New insights into factors affecting clot stability: a role for thrombin activatable fibrinolysis inhibitor (TAFI; plasma procarboxypeptidase B, plasma procarboxypeptidase U, procarboxypeptidase R). Seminars in Hematology 2004;41(1),13-9
23. Guimaraes AHC, Rijken DC. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration- dependent manner. Study of seven plasminogen activators in an internal clot lysis model. Journal of Thrombosis and Haemostasis 2004;91(3):473-9
24. Mandl-Weber S, Haslinger B, Sitter T. Thrombin upregulates production of plasminogen activator inhibitor type 1 in human peritoneal mesothelial cells. Peritoneal Dialysis International 1999;19(4):319-24
25. Chambers RC, Laurent GJ. Coagulation cascade proteases and tissue fibrosis. Biochemical Society Transactions 2002;30(2):194-200
26. Ramachandran R, Hollenberg MD. Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more. British Journal of Pharmacology 2008;153(1):S263-82
27. Riewald M, Ruf W. Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor. Proceedings of the National Academy of Sciences of the United States of America 2001;98(14):7742-7
28. White B, Perry D. Acquired antithrombin deficiency in sepsis. British Journal of Haematology 2001;112(1):26-31
29. Asakura H, Ontachi Y, Mizutani T, Kato M, Ito T, Saito M, Morishita E, Yamazaki M, Aoshima K, Takami A, Yoshida T, Suga Y, Miyamoto K, Nakao S. Decreased plasma activity of antithrombin or protein C is not due to consumption coagulopathy in septic patients with disseminated intravascular coagulation. European Journal of Haematology 2001;67(3):170-5
30. Camerer E, Rottingen J-A, Gjernes E, Larsen K, Skartlien AH, Iversen JG, Prydz H. Coagulation factors VIIa and Xa induce cell signaling leading to up- regulation of the egr-1 gene. Journal of Biological Chemistry 1999;274(45):32225-33
31. Chen D, Riesbeck K, McVey JH, Kemball-Cook G, Tuddenham EG, Lechler RI, Dorling A. Human thrombin and FXa mediate porcine endothelial cell activation; modulation by expression of TFPI-CD4 and hirudin-CD4 fusion proteins. Xenotransplantation 2001;8(4):258-65
32. Lindmark E, Siegbahn A. Tissue factor regulation and cytokine expression in monocyte-endothelial cell co-cultures: effects of a statin, an ACE-inhibitor and a low-molecular-weight heparin. Thrombosis Research 2002;108(1):77-84
33. Pernerstorfer T, Hollenstein U, Hansen JB, Knechtelsdorfer M, Stohlawetz P, Graninger W, Eichler HG, Speiser W, Jilma B. Heparin blunts endotoxin-induced coagulation activation. Circulation 1999;100(25):2485-90
34. Gori AM, Pepe G, Attanasio M, Falciani M, Abbate R, Prisco D, Fedi S, Giusti B, Brunelli T, Giusti B, Brunelli T, Comeglio P, Gensini GF, Neri Serneri GG. Tissue factor reduction and tissue factor pathway inhibitor release after heparin administration. Journal of Thrombosis and Haemostasis 1999;81(4):589-93
35. Gertz SD, Fallon JT, Gallo R, Taubman MB, Banai S, Barry WL, Gimple LW, Nemerson Y, Thiruvikraman S, Naidu SS, Chesebro JH, Fuster V, Sarembock IJ, Badimon JJ. Hirudin reduces tissue factor expression in neointima after ballon injury in rabbit femoral and porcine coronary arteries. Circulation 1998;98:580-7
36. Holschermann H, Bohle RM, Schmidt H, Zeller H, Fink L, Stahl U, Grimm H, Tillmanns H, Haberbosch W. Hirudin reduces tissue factor expression and attenuates graft arteriosclerosis in rat cardiac allografts. Circulation 2000;102(3):357-63
37. Souter PJ, Thomas S, Hubbard AR, Poole S, Romisch J, Gray E. Antithrombin inhibits lipopolysaccharide-induced tissue factor and interleukin-6 production by mononuclear cells, human umbilical vein endothelial cells, and whole blood. Critical Care Medicine 2001;29(1):134-9
38. Arai M, Uchiba M, Komura H, Mizuochi Y, Harada N, Okajima K. Metformin, an antidiabetic agent, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitro. Journal of Pharmacology and Experimental Therapeutics 2010;334(1):206-13
39. Napoleone E, Di Santo A, Camera M, Tremoli E, Lorenzet R. Angiotensin-converting enzyme inhibitors downregulate tissue factor synthesis in monocytes. Circulation Research 2000;86(2):139-43
40. Steffel J, Hermann M, Greutert H, Gay S, Luscher TF, Ruschitzka F, Tanner FC. Celecoxib decreases endothelial tissue factor expression through inhibition of c-Jun terminal NH2 kinase phosphorylation. Circulation 2005;111(13):1685-89
41. Kunieda Y, Nakagawa K, Nishimura H, Kato H, Ukimura N, Yano S, Kawano H, Kimura S, Nakagawa M, Tsuji H. HMG CoA reductase inhibitor suppresses the expression of tissue factor and plasminogen activator inhibitor-1 induced by angiotensin II in cultured rat aortic endothelial cells. Thrombosis Research 2003;110(4):227-34
42. Wang HY, Yang YM, Zhuang Y, Chen HN, Wan YL, Huang YT. The effect of celecoxib on tissue factor expression in pancreatic cancer cells. Chinese Medical Journal 2007;120(20):1753-6
43. Wei JL, Cui HM, Ma CY. Simvastatin inhibits tissue factor and plasminogen activator inhibitor-1 secretion by peripheral blood mononuclear cells in patients with primary nephrotic syndrome. European Journal of Medical Research 2007;12(5):216-21
44. Holschermann H, Terhalle HM, Zakel U, Maus U, Parviz B, Tillmanns H, Haberbosch W. Monocyte tissue factor expression is enhanced in women who smoke and use oral contraceptives. Journal of Thrombosis and Haemostasis 1999;82(6):1614-20
45. Reddy KV, Bhattacharjee G, Schabbauer G, Hollis A, Kempf K, Tencati M, O'Connell M, Guha M, Mackman N. Dexamethasone enhances LPS induction of tissue factor expression in human monocytic cells by increasing tissue factor mRNA stability. Journal of Leukocyte Biology 2004;76(1):145-51
46. Henrikson KP, Greenwood JA, Pentecost BT, Jazin EE, Dickerman HW. Estrogen control of uterine tissue factor messenger ribonucleic acid levels. Endocrinology 1992;130(5):2669-74
47. Matetzky S, Tani S, Kangavari S, Dimayuga P, Yano J, Xu H, Chyu KY, Fishbein MC, Shah PK, Cercek B. Smoking increases tissue factor expression in atherosclerotic plaques: implications for plaque thrombogenicity. Circulation 2000;102(6):602-4
48. Dardik R, Varon D, Tamarin I, Zivelin A, Salomon O, Shenkman B, Savion N. Homocysteine and oxidized low density lipoprotein enhance platelet adhesion to endothelial cells under flow conditions: distinct mechanisms of thrombogenic modulation. Journal of Thrombosis and Haemostasis 2000;83(2):338-44
49. Lockwood CJ, Krikun G, Runic R, Schwartz LB, Mesia AF, Schatz F. Progestin epidermal growth factor regulation of tissue factor expression during decidualization of human endometrial stromal cells. J Clin Endocrinol Metab 2000;85:297-301
50. Higgins JR, Walshe JJ, Darling MR, Norris L, Bonnar J. Haemostasis in the uteroplacental and peripheral circulation in normotensive and pre-eclamptic pregnancies. Am J Obstet Gynecol 1998;179:520-6
51. Carmeliet P, Mackman N, Moons L, Luther T, Gressens P, Van Vlaenderen I, Demunck H, Kasper M, Breier G, Evrard P, Muller M, Risau W, Edgington T, Collen D. Role of tissue factor in embryonic blood vessel development. Nature 1996;383:73-5
52. Bugge TH, Xiao Q, Kombrinck KW, Flick MJ, Holmback K, Danton MJS, Colbert MC, Witte DP, Fujikawa K, Davie EW, Degen JL. Fatal embryonic bleeding events in mice lacking tissue factor, the cell associated initiator of blood coagulation. Proc Natl Acad Sci USA 1996;93:6258-63
53. Toomey JR, Kratzer KE, Lasky NM, Stanton JJ, Broze Jr GJ. Targeted disruption of the murine tissue factor gene results in embryonic lethality. Blood 1996;88:1583-7
54. Lyall F, Belfort M. Pre-eclampsia. Etiology and clinical practice. Cambridge University Press 2007. P. 3-31,325-335,369
55. Šimetka O, Brychtova P, Prochazkova J, Prochazka M. Laboratorni změny aktivace endotelu u syndromu HELLP. Gynekolog 2008;2:48-53
56. Magee LA. Pre-eclampsia and increased cardivascular risk. Br Med J 2007;335:945-6
57. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and metaanalysis. Br Med J 2007;335:974-7
58. He S, Bremme K, Blomback M. Acquired deficiency of antithrombin in association with a hypercoagulable state and impaired function of liver and/or kidney in preeclampsia. Blood Coagul Fibrinolysis 1997;8:232-8
59. DG M. Hematologic evidence of disseminated intravascular coagulation in Pre-eclampsia. Obstet Gynecol Surv 1972;399-417
60. Howie PW, Prentice CR, McNicol GP. Coagulation, fibrinolysis and platelet function in pre-eclampsia, essential hypertension and placental insufficiency. J ObstetGynaecol Br Commonw 1971;78:992
61. Redman CWG, Denson KWE, Beilin LJ, Bolton FG, Stirrat GM. Factor- VIII consumption in pre-eclampsia. Lancet 1977;2:1249-52
62. Aznar J, Gilabert J, Estelles A, Espana F. Fibrinolytic-activity and protein-c in preeclampsia. Thromb Haemost 1986;55:314-7
63. Schjetlein R, Abdelnoor M, Haugen G, Husby H, Sandset PM, Wisloff F. Hemostatic variables as independent predictors for fetal growth retardation in preeclampsia. Acta Obstet Et Gynecol Scand 1999;78:191-7
64. Higgins JR, Walshe JJ, Darling MRN, Norris L, Bonnar J. Hemostasis in the uteroplacental and peripheral circulations in normotensive and pre-eclamptic pregnancies. Am J Obstet Gynecol 1998;179:520-6
65. Dusse LM, Carvalho MG, Getliffe K, Voegeli D, Lwaleed BA, Cooper AJ. Increased circulating thrombomodulin levels in pre-eclampsia. Clin Chim Acta 2008;387:168-71
66. Vince GS, Starkey PM, Austgulen R, Kwiatkowski D, Redman CWG. Interleukin-6, tumor-necrosis-factor and soluble tumor-necrosisfactor receptors in women with preeclampsia. Br J Obstet Gynaecol 1995;102:20-5
67. Dusse LM, Rios DRA, Pinheiro MB, Cooper AJ, Lwaleed BA. Preeclampsia: Relationship between coagulation, fibrinolysis and inflammation. Clinica Chimica Acta 2011;412:17-21
68. Di Paolo S, Volpe P, Grandaliano G. Increased placental expression of tissue factor is associated with abnormal uterine and umbilical Doppler waveforms in severe preeclampsia with fetal growth restriction. J Nephrol 2003;16:650-7
69. Erez O, Romero R, Hoppensteadt D, Than NG, Fareed J, Mazaki-Tovi S, Espinoza J, Chaiworapongsa T, Kim SS, Yoon BH, Hassan SS, Gotsch F, Friel L, Vaisbuch E, Kusanovic JP. Tissue factor and its natural inhibitor in pre-eclampsia and SGA. J Matern Fetal Neonatal Med 2008;21:855-69
70. Rousseau A, Favier R, Van Dreden P. Elevated circulating soluble thrombomodulin activity, tissue factor activity and circulating procoagulant phospholipids: new and useful markers for pre-eclampsia? Eur J Obstet Gynecol Reprod Biol 2009;146:46-9
71. Teng Y, Jiang R, Lin Q, Ding C, Ye Z. The relationship between plasma and placental tissue factor, and tissue factor pathway inhibitors in severe pre-eclampsia patients. Thromb Res 2010;126:e41-5
72. Dusse LM, Carvalho MG, Getliffe K, Voegeli D, Cooper AJ, Lwaleed BA. Total plasma tissue factor pathway inhibitor levels in pre-eclampsia. Clin Chim Acta 2008;388:230-2
73. Lopez-Ramirez Y, Carvajal Z, Arocha-Pinango CL. Hemostatic system parameters of placental extracts in normal pregnancy and severe preeclampsia. Invest Clin 2006;47:233-40
74. Godoi LC, Gomes KB, Alpoim PN, Carvalho MG, Lwaleed BA, Dusse LMSA. Preeclampsia: the role of tissue factor and tissue factor pathway inhibitor. J Thromb Thrombolysis 2012;34:1-6
75. Schjetlein R, Abdelnoor M, Haugen G, Husby H, Sandset PM, Wisloff F. Hemostatic variables as independent predictors for fetal growth retardation in preeclampsia. Acta Obstet Gynecol Scand 1999;78:191-7
76. Bujold E, Roberge S, Lacasse Y, Bureau M, Audibert F, Marcoux S, Forest JC, Giguere Y. Prevention of Preeclampsia and Intrauterine Growth Restriction With Aspirin Started in Early Pregnancy. Obstetrics & Gynecology 2010;116(2):402-14.